SCHEMBL2729692

SCHEMBL2729692

CCC1=NCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24756802 0.97 NOS3 (0.42)
SCHEMBL13742940 0.97 NOS3 (0.42)
SCHEMBL12020351 0.97 NOS3 (0.42)
SCHEMBL1357490 0.92
Iodide SCHEMBL16038836 0.87 NOS3 (0.35)
SCHEMBL14000046 0.83
SCHEMBL1760704 0.80
SCHEMBL8015557 0.75 CYP2D6 (0.41)
SCHEMBL22580208 0.74
SCHEMBL21317763 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10660333-B2 Substituted 2-heterocyclylimidazolylcarboxamides as pesticides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-05-26 US disclosed
US-20190166837-A1 SUBSTITUTED 2-HETEROCYCLYLIMIDAZOLYLCARBOXAMIDES AS PESTICIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-06-06 US disclosed
US-9682968-B2 Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof NOVARTIS AG (CH) 2017-06-20 US disclosed
US-20160152605-A1 Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses Thereof NOVARTIS AG (CH) 2016-06-02 US disclosed
EP-2632454-A1 HIV INTEGRASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2013-09-04 EP disclosed
EP-2299824-B1 PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME (US) 2013-06-19 EP disclosed
WO-2012058173-A1 HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2012-05-03 WO disclosed
WO-2012058173-A1 HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2012-05-03 WO disclosed
US-20110287494-A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINE DERIVATIVE DAICEL CHEMICAL INDUSTRIES LTD (JP) 2011-11-24 US disclosed
US-20110287494-A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINE DERIVATIVE DAICEL CHEMICAL INDUSTRIES LTD (JP) 2011-11-24 US disclosed
US-20110262977-A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINE DERIVATIVE DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2011-10-27 US disclosed
US-20110262977-A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINE DERIVATIVE DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2011-10-27 US disclosed
WO-2008047883-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENES FOR TREATMENT OF MENTAL DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-04-24 WO disclosed
US-7332149-B1 Vitronectin receptor antagonist pharmaceuticals BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2008-02-19 US disclosed
US-7321045-B2 Vitronectin receptor antagonist pharmaceuticals BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2008-01-22 US disclosed
EP-0591762-A1 Process for the preparation of polycarbonates and polyestercarbonates BAYER AG (DE) 1994-04-13 EP disclosed